Incidence and management of pleural effusions after diaphragm peritonectomy or resection for advanced mullerian cancer

被引:59
作者
Eisenhauer, Eric L.
D'Angelica, Michael I.
Abu-Rustum, Nadeem R.
Sonoda, Yukio
Jarnagin, William R.
Barakat, Richard R.
Chi, Dennis S.
机构
[1] Mem Sloan Kettering Canc Ctr, Gynecol Serv, Dept Surg, New York, NY 10021 USA
[2] Mem Sloan Kettering Canc Ctr, Hepatobil Serv, Dept Surg, New York, NY 10021 USA
关键词
ovarian cancer; cytoreduction; diaphragm surgery; pleural effusion;
D O I
10.1016/j.ygyno.2006.05.023
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Objectives. Diaphragm peritonectomy or resection is an effective way to cytoreduce diaphragm disease but frequently results in sympathetic pleural effusions. Our objective was to determine the incidence and management of effusions that developed after diaphragm surgery in patients with advanced mullerian cancer. Methods. We reviewed the records of all patients with stage IIIC-IV epithelial ovarian, fallopian tube, or peritoneal cancer who had diaphragm peritonectomy or resection as part of optimal primary cytoreduction at our institution from 2000-2003. All patients had preoperative and serial postoperative chest X-rays to detect and follow pleural effusions. Factors evaluated included the presence and size of preoperative and postoperative effusions, their laterality, and Subsequent need for thoracentesis and/or chest tube placement for symptomatic effusions. Results. Of the 215 patients who had primary cytoreduction during the study period, 59 (27%) underwent diaphragm peritonectomy or resection. In addition to standard cytoreduction, 31 (53%) of these 59 patients had diaphragm surgery alone, while 28 (47%) bad diaphragm surgery in combination with other upper abdominal resections. Laterality of diaphragm surgery was as follows: right only, 43 (73%); left only, 2 (3%)1- and bilateral, 14 (24%). Intraoperative chest tubes were placed in 7 (12%) patients. In the remaining 12 patients with preoperative effusions, postoperative effusions on the same side as the diaphragm surgery increased in 6 patients (50%), and 3 patients (25%) required postoperative thoracentesis or chest tube. In the remaining 40 patients without preoperative effusions, ipsilateral effusions developed in 24 patients (60%), and 5 patients (13%) required postoperative chest tubes. The overall rate of new or increased ipsilateral effusions was 58%; the overall rate of postoperative thoracentesis or chest tube placement was 15%. In 75% of the patients, thoracentesis or chest tubes were placed within 5 days of surgery (median, 3 days; range, 2-24). Conclusions. More than half of patients developed ipsilateral pleural effusions after diaphragm peritonectomy for cytoreduction. Most were managed conservatively without requiring a chest tube or thoracentesis. The incidence of symptomatic effusions was not high enough to recommend routine chest tube placement at the time of diaphragm peritonectomy or resection. (c) 2006 Elsevier Inc. All rights reserved.
引用
收藏
页码:871 / 877
页数:7
相关论文
共 24 条
[1]   Aggressive surgical effort and improved survival in advanced-stage ovarian cancer [J].
Aletti, GD ;
Dowdy, SC ;
Gostout, BS ;
Jones, MB ;
Stanhope, CR ;
Wilson, TO ;
Podratz, KC ;
Cliby, WA .
OBSTETRICS AND GYNECOLOGY, 2006, 107 (01) :77-85
[2]   Survival effect of maximal cytoreductive surgery for advanced ovarian carcinoma during the platinum era: A meta-analysis [J].
Bristow, RE ;
Tomacruz, RS ;
Armstrong, DK ;
Trimble, EL ;
Montz, FJ .
JOURNAL OF CLINICAL ONCOLOGY, 2002, 20 (05) :1248-1259
[3]   Improved optimal cytoreduction rates for stages IIIC and IV epithelial ovarian, fallopian tube, and primary peritoneal cancer: a change in surgical approach [J].
Chi, DS ;
Franklin, CC ;
Levine, DA ;
Akselrod, F ;
Sabbatini, P ;
Jarnagin, WR ;
DeMatteo, R ;
Poynor, EA ;
Abu-Rustum, NR ;
Barakat, RR .
GYNECOLOGIC ONCOLOGY, 2004, 94 (03) :650-654
[4]   Diaphragm resection for ovarian cancer: technique and short-term complications [J].
Cliby, W ;
Dowdy, S ;
Feitoza, SS ;
Gostout, BS ;
Podratz, KC .
GYNECOLOGIC ONCOLOGY, 2004, 94 (03) :655-660
[5]   SURGICAL APPROACH TO DIAPHRAGMATIC METASTASES FROM OVARIAN-CANCER [J].
DEPPE, G ;
MALVIYA, VK ;
BOIKE, G ;
HAMPTON, A .
GYNECOLOGIC ONCOLOGY, 1986, 24 (02) :258-260
[6]   Procedures required to accomplish complete cytoreduction of ovarian cancer: Is there a correlation with "biological aggressiveness" and survival? [J].
Eisenkop, SM ;
Spirtos, NM .
GYNECOLOGIC ONCOLOGY, 2001, 82 (03) :435-441
[7]   What are the current surgical objectives, strategies, and technical capabilities of gynecologic oncologists treating advanced epithelial ovarian cancer? [J].
Eisenkop, SM ;
Spirtos, NM .
GYNECOLOGIC ONCOLOGY, 2001, 82 (03) :489-497
[8]  
FIORICA JV, 1989, OBSTET GYNECOL, V74, P927
[9]  
HACKER NF, 1983, OBSTET GYNECOL, V61, P413
[10]  
HARTZ RS, 1984, J THORAC CARDIOV SUR, V87, P141